Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Avantor, Inc.AVTR · Entity 3546 | Director | May 07, 2026 | May 11, 2026 |
| Bruker Cellular Analysis, Inc.CELL · Entity 109250 | Director | October 02, 2023 | October 03, 2023 |
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director | June 03, 2026 | June 05, 2026 |
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | Director | June 09, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Avantor, Inc.
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,006 |
Reported balance
After 2026-05-07 transaction · row 1
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 25,270 · Balance 34,006 F1: Reflects a grant of restricted stock units that vests on May 7, 2027. |
| Common StockSEC Table I · non-derivative | IndirectBy a Trust | 60,000 |
Reported balance
After 2026-05-08 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-05-08 · Purchase · Acquired 10,000 · Balance 60,000 F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.30 to $8.32, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. F3: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units that vests on May 7, 2027.
F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.30 to $8.32, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above.
F3: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
Bruker Cellular Analysis, Inc.
Report date October 02, 2023 · Filed October 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectFamily Trust | 136,062 |
Reported balance
After 2023-10-02 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-10-02 · Exercise / conversion · Disposed 70,000 · Balance 136,062 F1: On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration"). F2: Pursuant to the Merger, the Reporting Person disposed of each RSU held by him in exchange for the Merger Consideration. |
| Common StockSEC Table I · non-derivative | IndirectFamily Trust | 0 |
Reported balance
After 2023-10-02 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2023-10-02 · Disposition to issuer · Disposed 136,062 · Balance 0 F3: Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the "Merger Consideration. F4: Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration").
F2: Pursuant to the Merger, the Reporting Person disposed of each RSU held by him in exchange for the Merger Consideration.
F3: Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the "Merger Consideration.
F4: Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration.
DENTSPLY SIRONA Inc.
Report date June 03, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-06-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-03 · Grant · Acquired 38,382 · Balance 38,382 F1: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Row 2 · 2026-06-03 · Gift · Disposed 38,382 · Balance 0 F2: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Partnership | 63,283.284 |
Reported balance
After 2026-06-03 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-06-03 · Gift · Acquired 38,382 · Balance 63,283.284 F2: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.64 · Expires 2036-06-03 | Direct | 10,900 |
Reported balance
After 2026-06-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-06-03 · Grant · Acquired 10,900 · Balance 10,900 F3: Stock Options vest in full one (1) year from date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.64 · Expires 2036-06-03 | Direct | 0 |
Reported balance
After 2026-06-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-06-03 · Gift · Disposed 10,900 · Balance 0 F4: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs. F3: Stock Options vest in full one (1) year from date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.64 · Expires 2026-06-05 | IndirectBy Family Partnership | 10,900 |
Reported balance
After 2026-06-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-06-03 · Gift · Acquired 10,900 · Balance 10,900 F3: Stock Options vest in full one (1) year from date of grant. F4: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs. |
| Common StockSEC Table I · non-derivative | IndirectBy Gregory Lucier IRA | 21,000 |
Reported balance
Holding disclosure · report date 2026-06-03 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 21,000 |
| Common StockSEC Table I · non-derivative | IndirectBy a Trust | 65,000 |
Reported balance
Holding disclosure · report date 2026-06-03 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 65,000 |
Filing footnotes · ownership attribution and instrument terms
F1: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.
F2: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose.
F3: Stock Options vest in full one (1) year from date of grant.
F4: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date June 09, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 155,123 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Gift · Disposed 46,293 · Balance 155,123 F1: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Family Partnership | 156,077 |
Reported balance
After 2026-06-09 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-06-09 · Gift · Acquired 46,293 · Balance 156,077 F1: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Catalent, Inc.
Report date December 18, 2024 · Filed December 18, 2024
Section 16 reporting ended · disclosed 2024-12-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-12-18 transaction · row 1
1 source rowRow 1 · 2024-12-18 · Disposition to issuer · Disposed 36,914 · Balance 0 F1: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F2: Includes restricted stock units ("RSUs"). F3: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration"). F4: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger").
F2: Includes restricted stock units ("RSUs").
F3: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration").
F4: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms.
Invuity, Inc.
Report date October 23, 2018 · Filed October 23, 2018
Section 16 reporting ended · disclosed 2018-10-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-10-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-10-23 · Disposition to issuer · Disposed 99,219 · Balance 52,231 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). Row 2 · 2018-10-23 · Disposition to issuer · Disposed 52,231 · Balance 0 F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2018-10-23 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2018-10-23 · Disposition to issuer · Disposed 18,245 · Balance 0 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). F4: The shares are held by RiverRoad Capital Partners, LLC, of which the Reporting Person is a managing member. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.15 · Expires 2024-01-21 | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-10-23 · Disposition to issuer · Disposed 24,648 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.87 · Expires 2021-05-19 | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-10-23 · Disposition to issuer · Disposed 28,900 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price").
F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock.
F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price.
F4: The shares are held by RiverRoad Capital Partners, LLC, of which the Reporting Person is a managing member.
F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option.
NUVASIVE INC
Report date May 18, 2021 · Filed May 20, 2021
Section 16 reporting ended · disclosed 2021-05-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectFamily Trust | 257,939 |
Last balance in matching sequence
After 2021-05-18 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2021-05-18 · Exercise / conversion · Acquired 19,125 · Balance 266,344 F1: On May 18, 2021, the Reporting Person retired from his position as a member of the Issuer's Board of Directors. Pursuant to deferral elections made by the Reporting Person, all shares underlying Restricted Stock Units ("RSUs") subject to such deferrals will be delivered to the Reporting Person promptly following May 18, 2021, the date on which the Reporting Person retired. F2: Shares indirectly held by the Reporting Person. Row 2 · 2021-05-18 · Tax withholding · Disposed 8,405 · Balance 257,939 F3: Shares withheld by the Issuer to satisfy tax withholding obligations. F2: Shares indirectly held by the Reporting Person. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-05-18 · Exercise / conversion · Disposed 8,312 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F5: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-05-18 · Exercise / conversion · Disposed 1,416 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F5: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-05-18 · Exercise / conversion · Disposed 3,725 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F6: This RSU award was granted to the Reporting Person on May 22, 2014 and is fully vested. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-05-18 · Exercise / conversion · Disposed 2,577 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F7: This RSU award was granted to the Reporting Person on May 9, 2019 and is fully vested. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-05-18 · Exercise / conversion · Disposed 3,095 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F8: This RSU award was granted to the Reporting Person on May 28, 2020 and is fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 18, 2021, the Reporting Person retired from his position as a member of the Issuer's Board of Directors. Pursuant to deferral elections made by the Reporting Person, all shares underlying Restricted Stock Units ("RSUs") subject to such deferrals will be delivered to the Reporting Person promptly following May 18, 2021, the date on which the Reporting Person retired.
F2: Shares indirectly held by the Reporting Person.
F3: Shares withheld by the Issuer to satisfy tax withholding obligations.
F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
F5: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested.
F6: This RSU award was granted to the Reporting Person on May 22, 2014 and is fully vested.
F7: This RSU award was granted to the Reporting Person on May 9, 2019 and is fully vested.
F8: This RSU award was granted to the Reporting Person on May 28, 2020 and is fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 10, 2026 21:06 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GiftClass A Common Stock | 46,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001251299-26-000005 · wk-form4_1781125571.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Partnership Disclosed balance after: 156,077 F1 · shares: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 21:06 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GiftClass A Common Stock | 46,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001251299-26-000005 · wk-form4_1781125571.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,123 F1 · shares: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 21:40 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GiftStock Option (Right to Buy) · Derivative | 10,900 | $0.00 Strike: $9.64 | $0.00 |
DisclosureSEC source: 0000818479-26-000193 · form4.xml · derivative · entry 8 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Partnership Disclosed balance after: 10,900 Underlying: Common Stock · 10,900 shares Expires 2026-06-05 F3 · derivative.exercise_price: Stock Options vest in full one (1) year from date of grant. F4 · shares: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 21:40 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GiftStock Option (Right to Buy) · Derivative | 10,900 | $0.00 Strike: $9.64 | $0.00 |
DisclosureSEC source: 0000818479-26-000193 · form4.xml · derivative · entry 7 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,900 shares Expires 2036-06-03 F4 · shares: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs. F3 · derivative.exercise_date: Stock Options vest in full one (1) year from date of grant. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 21:40 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 10,900 | $0.00 Strike: $9.64 | $0.00 |
DisclosureSEC source: 0000818479-26-000193 · form4.xml · derivative · entry 6 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,900 Underlying: Common Stock · 10,900 shares Expires 2036-06-03 F3 · derivative.exercise_date: Stock Options vest in full one (1) year from date of grant. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 21:40 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GiftCommon Stock | 38,382 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-26-000193 · form4.xml · nonDerivative · entry 3 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Partnership Disclosed balance after: 63,283.284 F2 · shares: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 21:40 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GiftCommon Stock | 38,382 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-26-000193 · form4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F2 · shares: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 21:40 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 38,382 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-26-000193 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,382 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 26, 2026 Filed May 28, 2026 22:49 UTC Amendment | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 46,293 | $0.00 | $0.00 |
DisclosureSEC source: 0001251299-26-000003 · wk-form4a_1780008548.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,416 F1 · shares: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. F2 · price: This Form 4 is being amended to correct the purchase price previously reported on a Form 4 filed this date. Read SEC document |
| May 26, 2026 Filed May 28, 2026 22:26 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 46,293 | $4.38 | $202,763.34 |
DisclosureSEC source: 0001251299-26-000001 · wk-form4_1780007172.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,416 F1 · shares: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on May 26, 2026, which vest in full upon the earlier of one year from the date of grant or the date of the 2027 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. Read SEC document |
| May 08, 2026 Filed May 11, 2026 20:39 UTC | Avantor, Inc. AVTR · Entity 3546 | PurchaseCommon Stock | 10,000 | $8.32 | $83,200.00 |
DisclosureSEC source: 0001628280-26-033605 · wk-form4_1778531950.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By a Trust Disclosed balance after: 60,000 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.30 to $8.32, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. F3 · balance_after: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| May 07, 2026 Filed May 11, 2026 20:39 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 25,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-033605 · wk-form4_1778531950.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,006 F1 · kind: Reflects a grant of restricted stock units that vests on May 7, 2027. Read SEC document |
| March 09, 2026 Filed Mar 9, 2026 20:20 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 15,000 | $12.45 | $186,675.00 |
DisclosureSEC source: 0000818479-26-000107 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By a Trust Disclosed balance after: 65,000 F1 · shares: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $12.43 to $12.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 00:12 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 22,445 | $14.03 | $314,858.46 |
DisclosureSEC source: 0000818479-26-000084 · form4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By a Trust Disclosed balance after: 50,000 F1 · shares: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $13.975 to $14.115, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 00:12 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 27,555 | $14.25 | $392,520.98 |
DisclosureSEC source: 0000818479-26-000084 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By a Trust Disclosed balance after: 27,555 F1 · shares: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $14.22 to $14.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 01:53 UTC | Avantor, Inc. AVTR · Entity 3546 | PurchaseCommon Stock | 50,000 | $9.16 | $458,000.00 |
DisclosureSEC source: 0001628280-26-010832 · wk-form4_1771898030.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By a Trust Disclosed balance after: 50,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $9.06 to $9.25, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. F2 · balance_after: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. Read SEC document |
| January 09, 2026 Filed Jan 13, 2026 21:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 341.114 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-26-000034 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Partnership Disclosed balance after: 24,901.284 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| December 08, 2025 Filed Dec 9, 2025 21:36 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | PurchaseClass A Common Stock | 48,528 | $3.67 | $178,097.76 |
DisclosureSEC source: 0001251299-25-000004 · wk-form4_1765316187.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,123 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.62 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4. Read SEC document |
| December 08, 2025 Filed Dec 10, 2025 21:26 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | SaleCommon Stock | 82,200 | $11.14 | $915,708.00 |
DisclosureSEC source: 0000818479-25-000288 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Share numbers were adjusted to include dividend accruals paid on the shares. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.04 to $11.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 21:36 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | PurchaseClass A Common Stock | 51,472 | $3.70 | $190,446.40 |
DisclosureSEC source: 0001251299-25-000004 · wk-form4_1765316187.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,595 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.679 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| October 14, 2025 Filed Oct 15, 2025 20:44 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GiftStock Option (Right to Buy) · Derivative | 17,200 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0000818479-25-000214 · form4.xml · derivative · entry 5 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Partnerhip Disclosed balance after: 17,200 Underlying: Common Stock · 17,200 shares Expires 2035-08-08 F2 · derivative.exercise_date: Stock Options vest in full one (1) year from date of grant. F3 · derivative.underlying_shares: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs. The reporting person disclaims beneficial ownership of these NQSOs except to the extent of his pecuniary interest therein, and the inclusion of these NQSOs in this report shall not be an admission that the reporting person is the beneficial owner of the NQSOs for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| October 14, 2025 Filed Oct 15, 2025 20:44 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GiftStock Option (Right to Buy) · Derivative | 17,200 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0000818479-25-000214 · form4.xml · derivative · entry 4 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,200 shares Expires 2035-08-08 F2 · derivative.exercise_date: Stock Options vest in full one (1) year from date of grant. F3 · derivative.underlying_shares: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs. The reporting person disclaims beneficial ownership of these NQSOs except to the extent of his pecuniary interest therein, and the inclusion of these NQSOs in this report shall not be an admission that the reporting person is the beneficial owner of the NQSOs for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| October 10, 2025 Filed Oct 15, 2025 20:44 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 310.397 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-25-000214 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Partnership Disclosed balance after: 24,357.397 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Family Partnership in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 21:04 UTC | Avantor, Inc. AVTR · Entity 3546 | GrantCommon Stock | 8,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001722482-25-000218 · wk-form4_1759871095.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,736 F1 · kind: Reflects a grant of restricted stock units that vests on October 3, 2026. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantStock Option (Right to Buy) · Derivative | 17,200 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0000818479-25-000161 · form4.xml · derivative · entry 5 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,200 Underlying: Common Stock · 17,200 shares Expires 2035-08-08 F3 · derivative.exercise_date: Stock Options vest in full one (1) year from date of grant. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GiftCommon Stock | 24,047 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-25-000161 · form4.xml · nonDerivative · entry 3 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Partnership Disclosed balance after: 24,047 F2 · shares: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GiftCommon Stock | 24,047 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-25-000161 · form4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,301.434 F2 · shares: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 3,858 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-25-000161 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,348.434 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 20:46 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 202.777 | $0.00 | $0.00 |
DisclosureSEC source: 0000818479-25-000128 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,490.434 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 10, 2025 Filed Jul 11, 2025 21:40 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GiftClass A Common Stock | 89,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001823239-25-000095 · wk-form4_1752270023.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Partnership Disclosed balance after: 109,784 F1 · shares: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| July 10, 2025 Filed Jul 11, 2025 21:40 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GiftClass A Common Stock | 89,139 | $0.00 | $0.00 |
DisclosureSEC source: 0001823239-25-000095 · wk-form4_1752270023.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,123 F1 · shares: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 22:24 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 89,139 | $2.16 | $192,540.24 |
DisclosureSEC source: 0001823239-25-000086 · wk-form4_1750285493.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,262 F1 · shares: Represents restricted stock units awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan on June 16, 2025, which vest in full upon the earlier of one year from the date of grant or the date of the 2026 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. Read SEC document |
| May 22, 2025 Filed May 27, 2025 21:23 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 20,189 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015712 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,287.657 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| April 11, 2025 Filed Apr 15, 2025 20:21 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 127.222 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-012077 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,098.657 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 03, 2025 Filed Mar 3, 2025 23:33 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 15,142 | $16.51 | $249,994.42 |
DisclosureSEC source: 0001127602-25-007590 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,971.435 F1 · shares: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $16.475 to $16.550, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 22:21 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 99.446 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-001223 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,829.435 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| December 18, 2024 Filed Dec 18, 2024 18:04 UTC | Catalent, Inc. CTLT · Entity 16279 | Disposition to issuerCommon Stock | 36,914 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-137720 · ownership.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F2 · shares: Includes restricted stock units ("RSUs"). F3 · price: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration"). F4 · price: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms. Read SEC document |
| December 09, 2024 Filed Dec 9, 2024 22:18 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GiftClass A Common Stock | 20,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001823239-24-000128 · wk-form4_1733782706.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Family Partnership Disclosed balance after: 20,645 F1 · shares: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| December 09, 2024 Filed Dec 9, 2024 22:18 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GiftClass A Common Stock | 20,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001823239-24-000128 · wk-form4_1733782706.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,123 F1 · shares: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose. Read SEC document |
| November 18, 2024 Filed Nov 18, 2024 21:16 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 5,000 | $18.37 | $91,849.50 |
DisclosureSEC source: 0001127602-24-027492 · form4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,729.989 Read SEC document |
| November 18, 2024 Filed Jan 29, 2025 23:14 UTC Amendment | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 5,000 | $18.37 | $91,849.50 |
DisclosureSEC source: 0001127602-25-002340 · form4a.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,729.989 F1 · balance_after: The balance reflects an adjustment to correct an error in the form of ownership (of 5,000 shares) from direct to indirect in the Gregory Lucier IRA. Read SEC document |
| November 15, 2024 Filed Nov 18, 2024 21:16 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 1,000 | $18.28 | $18,279.30 |
DisclosureSEC source: 0001127602-24-027492 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Gregory Lucier IRA Disclosed balance after: 16,000 Read SEC document |
| November 15, 2024 Filed Jan 29, 2025 23:14 UTC Amendment | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 1,000 | $18.28 | $18,279.30 |
DisclosureSEC source: 0001127602-25-002340 · form4a.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Gregory Lucier IRA Disclosed balance after: 21,000 F1 · balance_after: The balance reflects an adjustment to correct an error in the form of ownership (of 5,000 shares) from direct to indirect in the Gregory Lucier IRA. Read SEC document |
| October 30, 2024 Filed Nov 1, 2024 20:58 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 4,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-24-000099 · wk-form4_1730494727.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,914 F1 · shares: The equity acquired by the reporting person is the annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of (i) a "change in control" (as defined in the Catalent, Inc. 2018 Omnibus Incentive Plan) and (ii) one year from the date of award, subject to continued service. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 20:50 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 69.221 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-025511 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,729.989 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| August 08, 2024 Filed Aug 9, 2024 20:08 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 8,212 | $24.35 | $199,982.73 |
DisclosureSEC source: 0001127602-24-021933 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,660.768 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $24.305 to $24.38, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 21:05 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 74.688 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-020397 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,448.768 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| May 31, 2024 Filed Jun 3, 2024 20:21 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 3,577 | $27.95 | $99,976.43 |
DisclosureSEC source: 0001127602-24-017281 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,374.08 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $27.935 to $27.960, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 23, 2024 Filed May 24, 2024 20:22 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 11,628 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-016574 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,797.08 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 23, 2024 Filed May 24, 2024 21:56 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 20,645 | $10.78 | $222,553.10 |
DisclosureSEC source: 0001823239-24-000071 · wk-form4_1716587801.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,768 F1 · shares: Represents restricted stock units granted on May 23, 2024, which vest in full upon the earlier of one year from the date of grant or the date of the 2025 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.